Bever CT[au] - Search Results

Year	Number of Results
1955	1
1956	1
1981	1
1982	2
1983	2
1984	1
1985	4
1986	1
1988	2
1989	3
1990	2
1991	3
1992	1
1993	2
1994	3
1995	2
1996	3
1997	2
1998	7
1999	3
2001	7
2002	1
2003	2
2005	2
2006	2
2007	2
2008	4
2009	5
2010	5
2011	4
2012	4
2013	3
2014	2
2015	6
2016	6
2017	4
2018	1
2019	3
2020	2
2021	0

1

Robot-Assisted Arm Training in Chronic Stroke: Addition of Transition-to-Task Practice.

Conroy SS, Wittenberg GF, Krebs HI, Zhan M, Bever CT, Whitall J. Conroy SS, et al. Among authors: bever ct. Neurorehabil Neural Repair. 2019 Sep;33(9):751-761. doi: 10.1177/1545968319862558. Epub 2019 Jul 22. Neurorehabil Neural Repair. 2019. PMID: 31328671 Clinical Trial.

2

Robot-assisted therapy for long-term upper-limb impairment after stroke.

Lo AC, Guarino PD, Richards LG, Haselkorn JK, Wittenberg GF, Federman DG, Ringer RJ, Wagner TH, Krebs HI, Volpe BT, Bever CT Jr, Bravata DM, Duncan PW, Corn BH, Maffucci AD, Nadeau SE, Conroy SS, Powell JM, Huang GD, Peduzzi P. Lo AC, et al. Among authors: bever ct jr. N Engl J Med. 2010 May 13;362(19):1772-83. doi: 10.1056/NEJMoa0911341. Epub 2010 Apr 16. N Engl J Med. 2010. PMID: 20400552 Free PMC article. Clinical Trial.

3

Novel use of existing technology: A preliminary study of patient portal use for telerehabilitation.

Conroy SS, Harcum S, Keldsen L, Bever CT Jr. Conroy SS, et al. Among authors: bever ct jr. J Telemed Telecare. 2020 Sep 1:1357633X20950172. doi: 10.1177/1357633X20950172. Online ahead of print. J Telemed Telecare. 2020. PMID: 32869689

4

Comparing Home Upper Extremity Activity with Clinical Evaluations of Arm Function in Chronic Stroke.

Bhatnagar K, Bever CT, Tian J, Zhan M, Conroy SS. Bhatnagar K, et al. Among authors: bever ct. Arch Rehabil Res Clin Transl. 2020 Jun 18;2(2):100048. doi: 10.1016/j.arrct.2020.100048. Arch Rehabil Res Clin Transl. 2020. PMID: 33336184 Free PMC article.

5

Research Lifecycle to Increase the Substantial Real-world Impact of Research: Accelerating Innovations to Application.

Kilbourne AM, Braganza MZ, Bowersox NW, Goodrich DE, Miake-Lye I, Floyd N, Garrido MM, Frakt AB, Bever CT Jr, Vega R, Ramoni R. Kilbourne AM, et al. Among authors: bever ct jr. Med Care. 2019 Oct;57 Suppl 10 Suppl 3(10 Suppl 3):S206-S212. doi: 10.1097/MLR.0000000000001146. Med Care. 2019. PMID: 31517789 Free PMC article.

6

Practice improvement requires more than guidelines and quality measures.

Sigsbee B, Bever CT Jr, Jones LK Jr. Sigsbee B, et al. Among authors: bever ct jr. Neurology. 2016 Jan 12;86(2):188-93. doi: 10.1212/WNL.0000000000002116. Epub 2015 Oct 30. Neurology. 2016. PMID: 26519541 Review.

7

SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a review.

Nimmagadda VK, Makar TK, Chandrasekaran K, Sagi AR, Ray J, Russell JW, Bever CT Jr. Nimmagadda VK, et al. Among authors: bever ct jr. J Neuroimmunol. 2017 Mar 15;304:29-34. doi: 10.1016/j.jneuroim.2016.07.007. Epub 2016 Jul 17. J Neuroimmunol. 2017. PMID: 27474445 Free PMC article. Review.

8

Sustained-release fampridine for multiple sclerosis.

Bever CT, Judge SI. Bever CT, et al. Expert Opin Investig Drugs. 2009 Jul;18(7):1013-24. doi: 10.1517/13543780903002082. Expert Opin Investig Drugs. 2009. PMID: 19548855 Review.

9

Cell-based delivery of brain-derived neurotrophic factor in experimental allergic encephalomyelitis.

Makar TK, Nimmagadda VK, Trisler D, Bever CT Jr. Makar TK, et al. Among authors: bever ct jr. J Interferon Cytokine Res. 2014 Aug;34(8):641-7. doi: 10.1089/jir.2013.0160. Epub 2014 Mar 6. J Interferon Cytokine Res. 2014. PMID: 24601738 Review.

10

Tribute to John F. Kurtzke, MD, FACP, FAAN: 1926-2015.

Bever CT Jr, Wallin MT. Bever CT Jr, et al. Mult Scler. 2016 Mar;22(3):267-8. doi: 10.1177/1352458516632382. Mult Scler. 2016. PMID: 26951816 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results